US 12291530
GLP-1R agonist and therapeutic method thereof
granted A61KA61K31/437A61K31/4985
Quick answer
US patent 12291530 (GLP-1R agonist and therapeutic method thereof) held by Ascletis Pharma (China) Co., Limited expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ascletis Pharma (China) Co., Limited
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/437, A61K31/4985, A61K31/519, A61K31/5415